Newer Anemia Therapies
The management of anemia associated with kidney disease is undergoing a revolution as the safety of erythropoietin analogs is being challenged by newly recognized dangers [...]
Interview
Interviews are typically with authors on their recently published AJKD articles.
Hypertension and Symptomatic Hypokalemia
In this post, Dr. Pantelis Sarafidis (PS) discusses a case in AJKD on hypertension and symptomatic hypokalemia in a patient with simultaneous unilateral stenoses of [...]
“Peritoneal Dialysis” Strikes Back
In the United States, the number of patients who are offered peritoneal dialysis (PD) has declined over the last decade. The newer generation of Nephrologists may not feel as [...]
Vitamin D therapy in IgA Nephropathy
While vitamin D has shown to be beneficial in reducing proteinuria in patients with chronic kidney disease (CKD), the role of activated vitamin D replacement in IgA [...]
Family History of End-Stage Renal Disease: What does it mean for ESRD Risk?
In this post, Dr Tejas P. Desai, eAJKD web advisory board member and Dr. William Mc Clellan (WM) will share thoughts on a study published in the current issue of AJKD [...]
Cardiac Biomarkers in CKD and ESRD: What to make of them?
Dr. Akshay S. Desai (AD), cardiologist from Harvard Medical School, spoke with Dr Kellie Calderon (eAJKD), eAJKD web advisory board member, on the use of cardiac biomarkers [...]
Pemetrexed Nephrotoxicity
eAJKD Video Interview: Kidney Tubular Toxicity of Maintenance Pemetrexed Therapy Featuring Kenar Jhaveri, MD, eAJKD Blog Editor and Authors: Ilya Glezerman, MD Renal Service, [...]
Sulodexide in Diabetic Nephropathy: Is There a Role for This Novel Agent?
Sulodexide is a low molecular weight heparin (LMWH) that has no measurable anticoagulant effect when taken orally. Preliminary studies have shown that sulodexide has a [...]
The Nephrologists and the Internet!
Dr. Scott Gilbert (eAJKD), Education Editor of AJKD speaks with Dr. Matthew Sparks (MS) from Duke University Division of Nephrology on embracing the internet to enhance [...]
HLA-B Matching Priority Removal in Transplantation Allocation: Was it Worth It?
Dr. Dorry Segev (DS), Transplant Surgeon from Johns Hopkins Medical Center, recently discussed the removal of HLA-B matching priority in transplantation with Dr. Kenar [...]